GTX Genetix Grp

RNS Number:8384W
Genetix Group PLC
12 January 2006





                     Genetix Appoints new Finance Director



New Milton UK, 12th January 2006 - Genetix Group plc (LSE:GTX), the cell
biology, proteomics and genomics technology group, today announces the
appointment of Andrew Kellett, 37, as Finance Director with effect from  27th
March 2006.



Mr Kellett will be taking-up the position vacated by Gary Corsi who, as
previously notified, will be leaving the Company with effect from 31st January
2006.



Since February 2000, Mr Kellett has been with Quest Diagnostics Inc, a leading
provider of diagnostic testing, information & services to the healthcare
industry, and is currently Finance Director, Europe & Global Controller;
Clinical Trials & Pharmaceutical Business Development. He qualified as a
Chartered Accountant with Coopers & Lybrand in 1992 and has held senior
financial positions with MDC Corporation Inc, General Cable plc and United
Biscuits plc.



Mark Reid, CEO of Genetix said "We are delighted to welcome Andrew to the Board.
His experience with growing internationally based companies and recent exposure
to the business needs of pharmaceutical companies will be of particular benefit
to the executive team."





With reference to paragraphs 9.6.13 (1) - (6) of the FSA's Listing Rules there
are no disclosures required.





Enquiries

Genetix Group plc
Mark Reid, Chief Executive
Tel: 01425 624600

Financial Dynamics
Julia Phillips / Sarah MacLeod
Tel: 020 7831 3113





Notes to Editors



Genetix provides automated systems for cell biology, and proteomic and genomic
research.  It supplies many leading academic institutions worldwide and major
international companies involved in the drug discovery process including GSK,
AstraZeneca and Novartis.



Through its R&D expertise and scientific resource, Genetix is committed to the
continual development of innovative solutions to accelerate the rate of global
scientific discovery.  The Company made a significant contribution to the Human
Genome Project by supplying high-throughput equipment to seven of the eight
leading laboratories of the consortium.



Genetix is quoted on the London Stock Exchange (symbol GTX) and is based in New
Milton, Hampshire, UK.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAILFSLLLIFLIR

Genetix Grp (LSE:GTX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Genetix Grp (LSE:GTX)
Historical Stock Chart
From Jul 2023 to Jul 2024